Table 2. The effect of DBME on serum markers (ALAT, ASAT, ALP, bilirubin) in iron overloaded mice.

Treatment	ALAT (Unit/l)	% Change	ASAT (Unit/l)	% Change	ALP (Unit/l)	% Change	Bilirubin (mg/dl)	% Change
B	15.25 ± 1.56	-	67.60 ± 5.78	-	33.08 ± 3.71	-	1.52 ± 0.09	-
C	45.23 ± 2.45 c	196.63	167.62 ± 4.64 c	147.91	132.51 ± 6.42 c	300.57	3.28 ± 0.20 c	116.29
S50	38.38 ± 0.42 c e	151.72	105.44 ± 2.98 c f	55.95	107.88 ± 3.45 c f	226.11	3.03 ± 0.65 b	100.23
S100	28.43 ± 0.29 c f	86.45	99.04 ± 3.30 c f	46.48	64.89 ± 4.88 c f	96.17	2.13 ± 0.24 b f	40.27
S200	20.77 ± 0.48 c f	36.19	81.09 ± 3.09 b f	19.94	38.66 ± 3.72 b f	16.86	1.77 ± 0.13 b f	16.40
D	23.29 ± 1.09 c f	52.79	79.35 ± 4.36 a f	17.36	61.01 ± 2.44 c f	84.44	1.68 ± 0.15 f	10.97

Values are mean ± SD of six observations.

^a p<0.05

^b p<0.01 and ^c p<0.001 significant difference from normal mice (B) group

^e p<0.01 and ^f p<0.001significant difference from iron overloaded (C) group